Hydroxyurea Therapy for Neurological and Cognitive Protection in Pediatric Sickle Cell Anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial

Mboizi, V., Nabaggala, C., Munube, D., Ssenkusu, J. M., Kasirye, P., Kamya, S., Kawooya, M. G., Boehme, A., Minja, F., Mupere, E., Opoka, R., Rosano, C., Idro, R., & Green, N. S. (2024). Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial. Contemporary Clinical Trials Communications, 42, 101404. https://doi.org/10.1016/j.conctc.2024.101404

Authors:

Vincent Mboizi

Catherine Nabaggala

Deogratias Munube

John M. Ssenkusu

Phillip Kasirye

Samson Kamya

Michael Kawooya

Amelia K. Boehme

Frank J. Minja

Ezekiel Mupere

Robert Opoka